SCHEMBL11279285

SCHEMBL11279285

Oc1ccc(OCC(O)CNCCOc2ccccc2O)cc1

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 11/20 0.66
ADRB2 P07550 10/20 0.66
ADRB3 P13945 11/20 0.60
CYP1A2 P05177 1/20 0.57
ATM Q13315 1/20 0.55
DRD2 P14416 2/20 0.50
DRD4 P21917 2/20 0.50
DRD3 P35462 2/20 0.50
MEN1 O00255 1/20 0.50
OPRM1 P35372 1/20 0.50
OPRD1 P41143 1/20 0.50
KMT2A Q03164 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22279186 0.88 ADRB2 (0.81) ADRB1ADRB2ADRB3DRD2DRD4
SCHEMBL11274264 0.88 ADRB2 (0.81) ADRB1ADRB2ADRB3DRD2DRD4
SCHEMBL11279000 0.88 ADRB1 (0.60) ADRB1ADRB2ADRB3CYP1A2ATM
SCHEMBL9320639 0.87 ADRB2 (0.74) ADRB1ADRB2ADRB3CYP1A2ATM
SCHEMBL11275123 0.87 ADRB2 (0.74) ADRB1ADRB2ADRB3CYP1A2ATM
Hydrochloric Acid SCHEMBL10346478 0.85 ADRB2 (0.72) ADRB1ADRB2ADRB3CYP1A2ATM
SCHEMBL11364046 0.82 ADRB2 (0.73) ADRB1ADRB2ADRB3ATMDRD2
SCHEMBL11355780 0.82 ATM (0.59) ADRB1ADRB2ADRB3CYP1A2ATM
SCHEMBL11360960 0.82 KDM4E (0.58) ADRB1ADRB2ADRB3CYP1A2MEN1
SCHEMBL11356662 0.81 ADRB2 (0.54) ADRB1ADRB2ADRB3CYP1A2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0064487-A1 New substituted 3-(parasubstituted)phenoxy-1-alkylamino-propanol-2-s, as well as process for their preparation, pharmaceutical preparations containing same, and method for treating cardiac failure Aktiebolaget Hässle (SE) 1982-11-10 EP disclosed